← Christopher B. Granger

Papers by Christopher B. Granger

Page 1 · newest first

1. Community and EMS Interventions to Improve Survival in Cardiac ArrestNew England Journal of Medicine · 2026
2. RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and designAmerican Heart Journal · 2024
3. Sex differences in bystander cardiopulmonary resuscitation and survival to hospital discharge for public out-of-hospital cardiac arrests in North Carolina and Singapore: a retrospective cohort studyResuscitation Plus · 2026
4. The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney DiseaseCirculation · 2023
5. SYNTAX Score and Long-Term OutcomesJournal of the American College of Cardiology · 2017
6. Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal DiseaseJournal of the American College of Cardiology · 2020
7. Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial FibrillationJournal of the American College of Cardiology · 2014
8. Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac ArrestJournal of the American College of Cardiology · 2016
9. Atrial Fibrillation in the Setting of Acute Myocardial Infarction: The GUSTO-I Experience fn1fn1This study was funded by grants from Genentech, South San Francisco, California; Bayer Corporation, New York, New York; CIBA-Corning, Medfield, Massachusetts; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.Journal of the American College of Cardiology · 1997
10. Use of Anticoagulation Among Patients With Atrial Fibrillation or Atrial Flutter in the United StatesCirculation Population Health and Outcomes · 2026
11. High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.Journal of the American College of Cardiology · 2022
12. Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCIJournal of the American College of Cardiology · 2024
13. Randomized Trials Versus Common Sense and Clinical ObservationJournal of the American College of Cardiology · 2020
14. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac DeathCirculation · 2017
15. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive SummaryCirculation · 2012
16. Bridging Treatment Implementation Gaps in Patients With Heart FailureJournal of the American College of Cardiology · 2023
17. Preventing and Managing Bleeding With Anticoagulation for Atrial FibrillationJournal of the American College of Cardiology · 2021
18. Practical Management of Anticoagulation in Patients With Atrial FibrillationJournal of the American College of Cardiology · 2015
19. Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic DysfunctionJournal of the American College of Cardiology · 2006
20. Learning from regional heterogeneity in outcomes of patients with acute myocardial infarctionEuropean Heart Journal · 2013
21. Understanding and Targeting Inflammation in Acute Myocardial InfarctionJournal of the American College of Cardiology · 2018
22. Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working groupEuropean Heart Journal · 2019
23. Coronary Artery Disease in Patients ≥80 Years of AgeJournal of the American College of Cardiology · 2018
24. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive SummaryJournal of the American College of Cardiology · 2012
25. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation studyThe Lancet · 2016
26. Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial FibrillationJournal of the American College of Cardiology · 2024
27. Patients With Prolonged Ischemic Chest Pain and Presumed-New Left Bundle Branch Block Have Heterogeneous Outcomes Depending on the Presence of ST-Segment ChangesJournal of the American College of Cardiology · 2005
28. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial InfarctionCirculation · 2012
29. Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF AnalysisCirculation · 2026
30. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary DiseaseJournal of the American College of Cardiology · 2017
31. Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on WarfarinJournal of the American College of Cardiology · 2025
32. Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary SyndromesCirculation · 2008
33. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexCirculation · 2022
34. Lessons learned in the Apple Heart Study and implications for the data management of future digital clinical trialsJournal of Biopharmaceutical Statistics · 2022
35. Lost to Follow‐Up in Pragmatic Trials With Remote Follow‐Up: Insights From CONNECT‐HF and TRANSFORM‐HFJournal of the American Heart Association · 2026
36. Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart FailureJournal of the American College of Cardiology · 2012
37. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac SurgeryCirculation · 2016
38. AntithromboticsJournal of the American College of Cardiology · 2019
39. Clinical Patterns and Appropriateness of Apixaban Dosing in Patients With Atrial FibrillationJACC Advances · 2026
40. Outcomes With Warfarin in Atrial FibrillationJACC Advances · 2026
41. Heterogeneity of Treatment Effect of DOACs vs Warfarin in Atrial FibrillationJACC Advances · 2026
42. Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE TrialJournal of the American College of Cardiology · 2020
43. Clinical Evaluation of Factor XIa Inhibitor DrugsJournal of the American College of Cardiology · 2023
44. Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trialEuropean Heart Journal · 2015
45. Physical Activity and Mortality in Patients With Stable Coronary Heart DiseaseJournal of the American College of Cardiology · 2017
46. Digoxin and Mortality in Patients With Atrial FibrillationJournal of the American College of Cardiology · 2018
47. Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 DiabetesJournal of the American College of Cardiology · 2022
48. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarctionJournal of the American College of Cardiology · 1999
49. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive SummaryJournal of the American College of Cardiology · 2017
50. Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AFEuropean Heart Journal · 2024